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Dietary sphingolipids such as glucosylceramide (GlcCer) are potential nutritional factors associated with
prevention of metabolic syndrome. Our current understanding is that dietary GlcCer is degraded to
ceramide and further metabolized to sphingoid bases in the intestine. However, ceramide is only found
in trace amounts in food plants and thus is frequently taken as GlcCer in a health supplement. In the
present study, we successfully prepared konjac ceramide (kCer) using endoglycoceramidase I (EGCase I).
Konjac, a plant tuber, is an enriched source of GlcCer (kGlcCer), and has been commercialized as a dietary
supplement to improve dry skin and itching that are caused by a deﬁciency of epidermal ceramide. Nerve
growth factor (NGF) produced by skin cells is one of the itch factors in the stratum corneum of the skin.
Semaphorin 3A (Sema 3A) has been known to inhibit NGF-induced neurite outgrowth of epidermal nerve
ﬁbers. It is well known that the itch sensation is regulated by the balance between NGF and Sema 3A. In
the present study, while kGlcCer did not show an in vitro inhibitory effect on NGF-induced neurite
outgrowth of PC12 cells, kCer was demonstrated to inhibit a remarkable neurite outgrowth. In addition,
the effect of kCer was similar to that of Sema 3A in cell morphological changes and neurite retractions,
but different from C2-Ceramide. kCer showed a Sema 3A-like action, causing CRMP2 phosphorylation,
which results in a collapse of neurite growth cones. Thus, it is expected that kCer is an advanced konjac
ceramide material that may have neurite outgrowth-speciﬁc action to relieve uncontrolled and serious
itching, in particular, from atopic eczema.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Epidermal neurotrophins play an important role for pro-
liferation of structural skin cells such as keratinocytes, ﬁbro-
blasts, and mast cells, and regulate peripheral innervation [1].
Cutaneous functions of nerve growth factor (NGF) have been well
studied and known to maintain cutaneous innervation and cell
survival by protecting sensory neurons via retrograder B.V. This is an open access article
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).neurotrophic signaling [2]. It is also well known that the cuta-
neous level of NGF is regulated as an autocrine and paracrine
growth factor in all skin cells [3,4]. An excessive amount of NGF
shows an additional function as a pain or itch sensitizer via the
cutaneous innervation system. Epidermal NGF elevation stimu-
lates skin cells, inducing overproduction of NGF, sensitizing the
nociceptive nerve endings of sensory neurons, enhancing neurite
outgrowth, and resulting in structural changes of the innervation
system. Such extended neurites penetrate into the superﬁcial
layer of the skin and indicate hypersensitivity for external stimuli
[5]. Thus, the undesired NGF causes extension of itch-causing
nerve ﬁbers and severe or long-lasting, itching skin, such as
atopic eczema. To prevent external stimuli from inducing hy-
persensitivity of sensory neurons, epidermal ceramide is crucial
for maintenance of homeostasis of an epidermal barrier. Epi-
dermal ceramides are believed to be derived from pools of
sphingomyelin and glucosylceramide (GlcCer) from differentiated
keratinocytes via glucosylceramide synthase [6] andunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. (A). Chemical structure of typical ceramide species: C24Cer, one of the major species in human epidermis, and kCer, one of the major species in Amorphophallus
konjac. (B) Time course of EGCase I reaction. The enzyme reaction was performed at 37 °C in sodium acetate buffer pH 5.0 with kGlcCer, 135 nmol; EGCase I, 70.3 mU. After
the enzyme reaction, Bligh–Dyer extracts were prepared and were examined by development of TLC using chloroform:methanol:acetic acid (65:10:0.3, v/v) as solvent. TLC
plates were sprayed with 10% cupric sulfate in 8% phosphoric acid, and heated at 180 °C. Plates were generally recorded using a photo scanner. The area density was
quantitated using JustTLC software. (C) Bligh–Dyer extracts were subjected to medium pressure liquid chromatography on a Hi-Flash S column and programmed with a
linear gradient elution from chloroform:methanol:acetic acid (99:2:0.4, v/v) to chloroform:methanol:acetic acid (99:4:0.4, v/v) for 10 min. Column fractions were analyzed
by TLC as shown. (D) Molecular species of kCer and kGlcCer after EGCase I reaction were analyzed by LC–ESI–MS/MS. No differences in the relative amounts of kCer and
kGlcCer were seen in the combinations of sphingoid bases (d18:2, t18:1) and hydroxyl fatty acids (C16:0-OH, C18:0-OH, C20:0-OH, C22:0-OH, C23:0-OH, C24:0-OH).
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epidermal barrier of water permeability and external stimuli [8].
When this ceramide-enriched superﬁcial structure is injured or
acquires developmental dysfunctions, the external stimuli can
penetrate into the barrier and irritate the keratinocytes, or mast
cells and ﬁbroblasts, enhancing production and secretion of NGF
and inﬂammatory cytokines [1].
Konjac (Amorphophallus konjac K. Koch) is a food plant that isabundant in GlcCer. The efﬁcacy of konjac GlcCer (kGlcCer) in
trans-epidermal water loss in mice and humans has been studied
by Uchiyama et al. [9]. However, it remains to be elucidated
whether kGlCer and its metabolites have a direct effect on itch-
causing neurite outgrowth. In the present study, we examined
whether kGlcCer and konjac ceramide (kCer, see Fig. 1A
for its structure), which is a trace component of konjac extract,
possess an inhibitory effect on NGF-induced neurite outgrowth.
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doglycoceramidase I (EGCase I) [10] to perform cellular experi-
ments. We found remarkable neurite retractions caused by kCer,
but not by kGlcCer, in PC12 cells.
It is well known that extensions and retractions of skin sensory
nerve ﬁbers are regulated by the balance of nerve elongation
factors such as NGF and nerve repulsion factors such as sema-
phorin 3A (Sema 3A) [11]. Our ﬁndings presented here indicate
that kCer has a similar activity as Sema 3A, which is a growth
cone-modulator protein, via CRMP2 phosphorylation, and com-
petes with NGF in epidermal homeostasis [12].2. Materials and methods
2.1. kCer preparation
GlcCer from konjac was commercially obtained from Nagara
Science Co, Ltd. (Gifu, Japan). Thin-layer chromatography (TLC)
analysis showed homogeneous purity of kGlcCer to be more than
99%. Ten aliquots of kGlcCer (135 nmol each) were incubated
overnight (16–2 h) at 37 °C with 0.1 M sodium acetate buffer (pH
5.0) using recombinant EGCase I isolated from a mutant strain of
Rhodococcus erythropolis L-88 containing pTip-EGCI plasmid as
host cell [10,13]. After EGCase I treatment, samples were processed
using the Bligh–Dyer extraction method [14] and analyzed by TLC
using chloroform:methanol:acetic acid, 65:10:0.3, (v/v) as solvent.
Following chromatography, TLC plates were sprayed with 10%
cupric sulfate in 8% phosphoric acid, heated at 180 °C and recorded
with a photo scanner. The area density was quantitated using
JustTLC software (SWEDAY, Sodra Sanby, Sweden). The post-reac-
tion samples shown to contain kCer and kGlcCer by TLC were then
extracted by the Bligh–Dyer method. Ten of the Bligh–Dyer ex-
tracts were pooled and dried by nitrogen gas. The pooled crude
samples were subjected to medium pressure liquid chromato-
graphy on a Hi-Flash S column (Yamazen Corp., Osaka, Japan), and
separated into two column fractions containing kCer and kGlcCer,
eluted such that one column fraction contained kCer and one
fraction contained kGlcCer. The column fraction containing kCer
was detected by TLC analysis with cupric sulfate/phosphate re-
agent, pooled, and dried by nitrogen gas. The combined kCer was
quantitated by TLC-densitoscanning as described above. The kCer
thus prepared was used for in situ treatment on PC12 cells in
culture.
2.2. Neurite outgrowth assay
Rat adrenal pheochromocytoma PC12 cells were obtained from
JCRB Cell Bank (Osaka, Japan). Cells were cultured in Dulbecco's
modiﬁed Eagle's medium (DMEM) supplemented with 10% fetal
bovine serum (FBS), 5% horse serum (HS), and 10 ml/L penicillin–
streptomycin solution (Wako Co, Osaka, Japan), maintained at
37 °C in a humidiﬁed chamber under an atmosphere of 95% air and
5% CO2. NGF (mNGF 2.5 S, Almone Labs, Jerusalem, Israel) was
dissolved in 0.025% bovine serum albumin (BSA)/DMEM contain-
ing kCer (or other ceramides: C2Cer, C16Cer, C18Cer). For NGF-
induced differentiation, PC12 cells were plated in poly-L-lysine-
coated 24-well plates at 3.0104 cells /well and incubated in
DMEM with 10% FBS/5% HS overnight. Cells were washed with
fresh serum-free DMEM and incubated for 48 hours with 0.025%
BSA/DMEM containing the ceramides in the presence or absence
of NGF (100 ng/mL). After removing the supernatant by suction,
phosphate-buffered saline (PBS) solution containing 2% glutar-
aldehyde was gently overlaid to ﬁx cells at room temperature for
20 min. The glutaraldehyde solution was changed to 1% Coomassie
Brilliant Blue (CBB) G-250 solution (1% CBB in 50% methanol/PBS),and cells were incubated for 2 hours at room temperature. Cells
were then destained with 50% methanol/PBS, and washed with
PBS. Bright-ﬁeld cell images were obtained using light microscopy
at 20-fold magniﬁcation (BZ-X700 All-in-one Fluorescence Mi-
croscope, KEYENCE, Osaka, Japan), and color image-processing of
contour segmentation was performed using Hydrid Cell Count
Module internal software. The image area was divided into two
regions: neurites and cell nucleus with pale and deep color seg-
mentation, respectively. The area ratio of image extract-2 (neur-
ites) to image extract-1 (neuritesþcell nucleus) was calculated as
percentage of neurite outgrowth activity.
2.3. In vitro cell viability assay
The cytotoxic effects of kCer, C16Cer, C18Cer, and C2Cer in PC12
cells were determined by conventional trypan blue exclusion assay
(TBEA), lactate dehydrogenase (LDH) test, and extracellular re-
duction of WST-8 by electron mediator produced in cells (CCK-8).
The ceramides were dissolved in 0.025%BSA/DMEM medium and
added to the cultures. PC12 cells were treated with ceramides
alone for 2 hours for the LDH test and 24 hours for TBEA and CCK-
8, and incubated at 37 °C and 5% CO2.
2.4. CRMP2 phosphorylation assay
PC12 cell monolayers in 6-well plates were treated with NGF
(100 ng/mL) for 48 hours, then replaced with fresh DMEM con-
taining either kCer (25 μM) or Sema 3A (250 ng/mL), and in-
cubated for 0.5–24 h. After treatment, cells were lysed in a solu-
tion of Protein Inhibitor Cocktail II (Calbiochem, Darmstadt, Ger-
many), and protein concentrations were adjusted to 1 μg/μL ac-
cording to protein determinations by a bicinchoninate protein
assay kit (Nacalai Co, Kyoto, Japan). Proteins (20 μg) were sepa-
rated by SDS-PAGE with 7% polyacrylamide under reducing con-
ditions and transferred to polyvinylidene diﬂuoride (PVDF; Bio-
Rad, Hercules, CA) membranes by semi-dry blotting (Trans-Blot SD
Cell, Bio-Rad, Hercules, CA). The resultant Western blots were
blocked by incubation with blocking solution (BLOCKING ONE,
Nacalai.Co., Kyoto, Japan) and then incubated overnight at 4 °C
with primary antibodies for CRMP2, pCRMP2, and actin. The blots
were incubated for 1 h with peroxidase-coupled secondary anti-
body (Jackson Laboratory, Bar Harbor, ME). After extensive wash-
ings, antibody binding was visualized with Chemi-Lumi One Super
reagent (Nacalai.Co., Kyoto, Japan). The developed bands were
quantiﬁed using JustTLC software.
2.5. LC–ESI–MS/MS analysis
A Prominence UFLC system (Shimadzu, Kyoto, Japan) coupled
to a TripleTOF 5600 System (AB SCIEX, Foster City, CA, USA) was
used for kGlcCer and kCer analyses. kGlcCer or kCer was injected
onto an InertSustain column (5 μm, 2.1 i.d150 mm, GL Science,
Tokyo, Japan). Mobile phase A was acetonitrile:methanol:formic
acid (95:5:0.2, v/v) containing 5 mM ammonium formate, and
mobile phase B was methanol:formic acid (100:0.2, v/v) contain-
ing 5 mM ammonium formate. Samples were eluted at 0.2 mL/min
through a 45 min gradient: mobile phase B, 0–5 min 0%, 5–10 min
from 0% to 20%, 10–12 min hold 20%, 12–15 min from 20% to 50%,
15–22 min hold 50%, 22–27 min from 50% to 80%, 27–30 min hold,
and 30–45 min from 80% to 0%. TOF–MS and MS/MS analysis were
run in the positive ion mode with the following instrument
parameters: curtain gas of 10, ion spray voltage of 5500 and
temperature of 300 °C. The level of collision energy of each target
was optimized. High resolution-multiple reaction monitoring
(MRM–HR) mode was used to quantify the contents of each target.
Data acquisition and analysis were performed using AnalystTF
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2.6. Statistical analysis
The number (n) in each experimental condition is indicated in
the. Data analysis was performed using the commercial program
Prism 4.0 (GraphPad, San Diego, CA). When two experimental
conditions were compared, statistical analysis was performed
using an unpaired t test. Otherwise, statistical analysis was per-
formed by one-way ANOVA followed by Tukey's Multiple Com-
parison post-test and Dunnet's test. A P value less than 0.05 was
considered signiﬁcant. * indicates signiﬁcantly different results.
Ranges of P values are indicated in the. NS indicates non-
signiﬁcant.3. Results
3.1. Yield of EGCase I reaction
Ito M, et al. reported that globo-series glycosphingolipids are
hydrolyzed to some extent by EGCase I, but that GlcCer is hardly
hydrolyzed by the enzyme [10]. In spite of enzymatic hydrolysis
resistance, we improved the efﬁciency of kGlcCer hydrolysis up to
nearly 100% conversion by increasing the enzyme amount in the
presence of 1% Triton X-100 (data not shown). However, because
of residual toxicity of Triton X-100, we performed EGCase I reac-
tions without any detergent, but were able to reach increased kCer
production by elongation of the incubation time. However, the
yield was not beyond 50% (Fig. 1B). The kCer thus prepared could
be separated from unreacted kGlcCer by medium-performance
liquid chromatography up to 95% of TLC-grade (Fig. 1C). One unit
of EGCase I was deﬁned as the amount of enzyme that hydrolyzes
1 μmol of kGlcCer per min as a donor substrate. In that condition,
the enzyme unit per tube used was 70.3 mU (kGlcCer, 135 nmol;
250 μg of enzyme protein for 16 hour incubation). To determine
the molecular species of kCer and unreacted kGlcCer afterFig. 2. (A) Cytotoxicity of kCer, C2Cer, C16Cer, and C18Cer was determined by LDH rel
represent the means of four individual experiments with standard deviations, and
***Po0.001 vs. vehicle-treated controls (0 μM). (B) PC12 cells were cultured at 1.6104 c
C2Cer (5 μM) in the presence of 100 ng/mL of NGF. After 2% glutaraldehyde ﬁxation, cellsEGCase I reaction, LC–MS/MS analysis was performed using
kCer and kGlcCer puriﬁed from Bligh–Dyer extraction by medium-
performance liquid chromatography. We found that 6 species of
ceramides were present in both kCer and kGlcCer preparations
(Fig. 1D). The majority of the molecular species was a combination
of sphingoid base (d18:2) and hydroxyl fatty acid (C18:0-OH) as
shown in Fig. 1A, right panel. There was no remarkable difference
in the molecular species between kCer and kGlcCer.
3.2. Cell toxicity of kCer
Cytotoxicity of kCer was examined by either 2-hour treatment
of PC12 cells followed by LDH release test or 24-hour treatment of
PC12 cells followed by TBEA and CCK-8 tests. As shown in Fig. 2A
(left panel), kCer and 3 other ceramides (C16Cer, C18Cer, and
C2Cer) showed dose-dependent (from 10 μM to 100 μM) LDH re-
lease. The decreasing order of toxicity was C2Cer, C16Cer, C18Cer,
and kCer. On the other hand, the percentage of live cells via TBEA
was hardly inﬂuenced by C16Cer and C18Cer, but inﬂuenced
weakly by kCer and strongly by C2Cer (middle panel). Similar
trends of toxicity to TBEA were observed by CCK-8 test (right pa-
nel). The IC50 of kCer was 80 μM by TBEA, and 50 μM by CCK-8.
The CCK-8 test appeared to be somewhat more sensitive than
TBEA.
3.3. Neurite outgrowth activity and cell morphological changes
PC12 cells were induced to differentiate by NGF in the presence
of kCer or C2 ceramide, and cultures were ﬁxed and stained with
CBB as described in Section 2 (Fig. 2B). NGF-induced neurite out-
growth was analyzed as color phase-based images by BXZ-700
microscopy (Fig. 3A). The image ratios of extracts 1 and 2 showed
linearity with the treatment dose of NGF (Fig. 3B).
kCer treatment inhibited neurite extensions, resulting in a few
remaining long neurites, and loss of short neurites (Fig. 2B, second
panel, and Fig. 3C). Treatment with kCer caused a change in cell
morphology, to a spindle shape, as compared with a controlease test (2-hour treatment), TBEA, and CCK-8 test (24-hour treatment). The data
analyzed by one-way ANOVA. Values are indicated by *Po0.05, **Po0.01, and
ells/cm2 in a 24-well plate, and treated with kCer (50 μM), Sema 3A (250 ng/mL), or
were stained by 1% CBB and photographed (20 magniﬁcation). Scale bar, 100 μm.
Fig. 3. (A) Neurite outgrowth activity was measured by color image-processing. The area ratio of image extract-2 (neurites) to image extract-1 (neuritesþcell nucleus) was
calculated as the percentage of neurite outgrowth activity. Scale bar, 100 μm. (B) Neurite outgrowth activity correlated with NGF dose. The data represent the means of four
individual experiments with standard deviations. **Po0.01, **Po0.001 vs. vehicle-treated controls (0 ng/mL NGF) respectively by one-way ANOVA. (C) Effect of 50 μM kCer
on NGF-induced neurite outgrowth. Scale bar, 100 μm. (D) Inhibitory effect of kCer on NGF-induced neurite outgrowth. The data represent the means of four individual
experiments with standard deviations. *Po0.05, **Po0.001 vs. vehicle-treated control (0 μM) respectively by one-way ANOVA. (E) Comparison of inhibitory effects on NGF-
induced neurite outgrowth in the presence of 50 μM kCer, kGlcCer, C16Cer, C18Cer, and C2Cer. The data represent the means of four individual experiments with standard
deviations. ***Po0.0001 vs. vehicle-treated control (0 μM) respectively by one-way ANOVA.
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Fig. 4. (A) Effect of pretreatment by kCer and C2Cer on NGF-induced neurite outgrowth of PC12 cells. Cells were pretreated with kCer (10–100 μM) or C2Cer (10–50 μM) with
serum-free DMEM for 16 hours in a CO2 incubator. The media was removed and replaced with DMEM containing NGF (100 ng/mL) in the presence of kCer (10–100 μM) or
C2Cer (10–50 μM), respectively. After 48 hours, cells were subjected to CBB stain and tested for neurite outgrowth activity. The data represent the means of four individual
experiments with standard deviations. *Po0.05, **Po0.01 vs. no-treatment, respectively, by an unpaired t test. NS, not signiﬁcant. (B) Effect of kCer and C2 Cer on neurite
length of NGF-induced neurite outgrowth of PC12 cells. Neurite length was compared with cell body. Long neurite, more than 2-fold increase in length; short neurite, less
than 2-fold increase in length; and no neurite, less than 1/10-fold original length. (C) NGF-induced CRMP2 production. PC12 cells were treated with NGF and analyzed by
Western blotting using anti-CRMP2 antibody as described in Section 2. The data represent the means of three individual experiments with standard deviations. **Po0.01,
**Po0.001, vs. control time (0-hour) respectively by one-way ANOVA. (D) Time course of CRMP2 phosphorylation by kCer (25 μM) and Sema 3A (250 ng/mL) treatment after
NGF-induced differentiation of PC12 cells for 48 hours analyzed by Western blot (left panel). Quantitation of CRMP2 phosphorylation is calculated as the ratio of pCRMP2 to
CRMP2 (right panel). The data represent the means of three individual experiments with standard deviations.
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This morphological change by co-treatment with kCer was also
found with Sema 3A (Fig. 2B, third panel). On the other hand, cells
treated with NGF and C2Cer showed a remarkable inhibition of
neurite outgrowth (Fig. 2B, fourth panel, and Fig. 3E), resulting in
cells losing long neurites with a few remaining short neurites. The
cells grown in the presence of NGF and C2Cer showed round cell
morphology. The neurite-inhibiting effect of kCer was dose-de-
pendent at the range of 0 to 100 μM (Fig. 3D), and was speciﬁc to
kCer at 50 μM, as compared with no inhibition by C16Cer and
C18Cer (Fig. 3E). Sema 3A inhibited NGF-induced neurite out-
growth up to 35% of control (Fig. 3E), by neurite retractions with
similar cell morphology as NGFþ kCer treatment (Fig. 2B).
In contrast, kGlcCer showed no effect on neurite outgrowth
(Fig. 3E). The effect on neurite outgrowth by pretreatment with
kCer was dose-dependent, in contrast to C2Cer (Fig. 4A). The
pretreatment of cells with kCer (or C2Cer) also remarkably in-
creased the number of cells with long (or short) neurites and
spindle (or star) cell shape, and was dose-dependent (Fig. 4B). The
enhancing effect of kCer was also seen with treatment by Sema 3A.
3.4. CRMP2 phosphorylation
CRMP2 is an intracellular messenger within the Sema3A sig-
naling cascade. Phosphorylation of CRMP2 is essential for Sema 3A
activity. To examine the effects of kCer on CRMP2 phosphorylation,
cells were treated with 100 ng/mL of NGF for 24 or 4 hours and
analyzed by Western blotting (Fig. 4C). CRMP2 expression was
induced and reached a maximal level at 48 hours. Cells were then
treated with either Sema 3A (250 ng/mL) or kCer (25 μM) for 24
hours. CRMP2 phosphorylation was observed with both Sema 3A
and kCer (Fig. 4D). Sema 3A induced CRMP2 phosphorylation
earlier (at 0.5 hours) and reached a plateau level at 16 hours. In
contrast, kCer treatment induced a more gradual rate of phos-
phorylation of CRMP2, although it also plateaued at 16 hours
(Fig. 4D). In addition, C2Cer treatment did not show any phos-
phorylation of CRMP2.4. Discussion
GlcCer isolated from food plants has recently been studied
[15,16] and is used for health foods and cosmetics. The sphingoid
bases of GlcCer are structurally different from animal sphingosine
(Fig.1A) [17]. These differences are believed to be the reason for
the health-scientiﬁc effectiveness of the food plant GlcCer. The
food plant sphingoid bases have also been studied, and d18:2 and
t18:1 sphingoids have been demonstrated to bind peroxisome
proliferator-activated receptor (PPAR)γ, up-regulating de novo
ceramide synthesis of very long-chain fatty acids in differentiated
keratinocytes [18,19]. On the other hand, food plant ceramides
that are an intermediate between GlcCer and sphingoid base have
not been studied at all, and it is unclear why food plants include
trace amounts of ceramides such as kCer.
In the present study, we successfully chemoenzymatically iso-
lated a homogenous preparation of kCer, found in trace amounts in
konjac extracts. This new ceramide material was shown to inhibit
NGF-induced neurite outgrowth in rat adrenal pheochromocyto-
ma cells, PC12. Because this inhibitory activity was caused by kCer
but not kGlcCer, the speciﬁc hydrophilic or hydrophobic structure
of the kCer molecule seemed to be essential for its activity. This
activity is lacking in animal ceramides such as C16Cer and C18Cer.
In addition, the mode of inhibition by kCer was characterized by
suppressing short neurite sprouting and outgrowth and leaving
long neurites, and was accompanied by a cell morphological
change from star-shape to spindle-shape. These effects by kCer is aSema 3A-like action that preserves the balancing of NGF/Sema 3A.
There are two types of itch to be discriminated by whether the
skin permeability barrier is normal or not. kCer has a Sema3A-like
action, implicating that kCer may be effective for itching from
abnormalities or dysfunctions of the skin permeability barrier.
C2Cer strongly inhibited PC12 neurite outgrowth, and was ac-
companied by the disappearance of long neurites and by a round
morphology (Fig. 2B, fourth panel, and Fig. 4B). Although C2Cer
produced neurite retractions, CRMP2 phosphorylation was not
caused by treatment with C2Cer (Fig. 4D). Thus, C2Cer action
seemed to be cytotoxic rather than neurite-retractive, which is
completely different from the action of kCer causing CRMP2
phosphorylation and spindle-shaped long neurite outgrowth.
In the ﬁrst step of cell signaling, Sema 3A constitutes a het-
erotrimer complex with its receptor neuropilin1 and plexin A1 on
the cell surface [20,21]. This receptor complex activates GSK3β and
Cdk5, causing CRMP2 phosphorylation downstream of Sema 3A
signaling [22]. pCRMP2 no longer binds to tubulin, leading to de-
stabilization and depolymerization of microtubules, leading to
collapse of the growth cone [23]. This mechanism of growth cone
stability is maintained by a quantitative relationship between NGF
and Sema 3A. Our ﬁndings of cell morphological effects and
CRMP2 phosphorylation by kCer suggest that it works as a Sema
3A-like agonist.
Thus, we expect that chemoenzymatically prepared konjac
ceramide can be used as a beneﬁcial alternative for Sema 3A for
treating itching diseases and syndromes.Competing interests
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